We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Presurgical Diabetics Imperiled When Glucose Is Normal

By LabMedica International staff writers
Posted on 03 Nov 2010
Diabetic patients who presented for noncardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their nondiabetic counterparts.

There appears to be the relationship between blood sugar levels before surgery and the occurrence of complications and death after noncardiac surgeries, comparing the relationship between those with diabetes and those without.

In a study carried out at the Cleveland Clinic (Cleveland, OH, USA), specific data from surgeries on 61,536 patients who had elective surgery between January 2005 and November 2009, were analyzed. More...
The overall findings were that 15.8% had diabetes. The study examined two main outcomes: in-hospital complications after surgery (including cardiac, neurological, urologic, and infectious complications) and death within one year of surgery. The study analyzed such associations using both crude and adjusted figures. The adjusted figures took into account other factors that may have contributed to poor outcomes, such as age and heart disease.

The study found that the relationship between blood sugar levels and the likelihood of complications after surgery was not significantly different between diabetics and nondiabetics. However, the investigation showed a significant difference between diabetics and nondiabetics in terms of the relationship between blood sugar levels before surgery and deaths within one year of surgery. Nondiabetic patients with high blood sugar levels had a higher risk of dying from noncardiac surgery compared with diabetics with high blood sugar levels. Conversely, normal blood sugar levels in diabetics were associated with a higher risk of death within one year after noncardiac surgery versus nondiabetics.

Basem Abdelmalak, M.D., the study investigator, said, " Diabetics who have lived with high blood sugar for long periods of time have become accustomed to this state and may have reset their metabolism, becoming unable to tolerate lower blood glucose levels. This is similar to what happens to patients with long-term high blood pressure." The clinical study was presented at the annual meeting of the American Society of Anesthesiologist, held October 16-20, 2010, in San Diego, CA, USA.

Related Links:

Cleveland Clinic




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.